Clorox (CLX) Expected to Announce Quarterly Earnings on Monday

Clorox (NYSE:CLX) is expected to post its Q3 2025 quarterly earnings results after the market closes on Monday, May 5th. Analysts expect the company to announce earnings of $1.61 per share and revenue of $1.74 billion for the quarter. Clorox has set its FY 2025 guidance at 6.950-7.350 EPS.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Trading Up 0.2 %

CLX opened at $138.88 on Friday. The stock has a market capitalization of $17.11 billion, a P/E ratio of 37.95, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The firm’s fifty day simple moving average is $144.14 and its 200 day simple moving average is $154.91.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.51%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CLX shares. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Barclays decreased their target price on shares of Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research report on Friday, April 11th. Wells Fargo & Company cut their price target on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 16th. Finally, Citigroup decreased their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.